Adial Pharmaceuticals, Inc.
ADIL
$0.68
$0.00520.77%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.06M | 5.36M | 5.34M | 5.11M | 5.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.28M | 8.13M | 7.27M | 6.46M | 6.89M |
| Operating Income | -8.28M | -8.13M | -7.27M | -6.46M | -6.89M |
| Income Before Tax | -13.20M | -13.03M | -12.19M | -11.24M | -7.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.20 | -13.03 | -12.19 | -11.24 | -7.00 |
| Earnings from Discontinued Operations | -- | -15.90K | -53.20K | 2.54M | 1.88M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.20M | -13.05M | -12.24M | -8.69M | -5.12M |
| EBIT | -8.28M | -8.13M | -7.27M | -6.46M | -6.89M |
| EBITDA | -8.28M | -8.13M | -7.27M | -6.46M | -6.89M |
| EPS Basic | -3.48 | -3.98 | -4.78 | -3.23 | -3.78 |
| Normalized Basic EPS | -1.70 | -1.53 | -2.02 | -2.48 | -3.38 |
| EPS Diluted | -3.48 | -3.98 | -4.78 | -3.23 | -3.79 |
| Normalized Diluted EPS | -1.70 | -1.53 | -2.02 | -2.48 | -3.38 |
| Average Basic Shares Outstanding | 19.39M | 15.31M | 10.65M | 7.60M | 5.70M |
| Average Diluted Shares Outstanding | 19.39M | 15.31M | 10.65M | 7.60M | 5.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
